Jacobs Levy Equity Management, Inc Incyte Corp Transaction History

Jacobs Levy Equity Management, Inc

  • $23.9 Billion
  • Q3 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Incyte Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,743,794 shares of INCY stock, worth $182 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
1,743,794
Previous 1,294,883 34.67%
Holding current value
$182 Million
Previous $88.2 Million 67.71%
% of portfolio
0.62%
Previous 0.36%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 17, 2025
BUY
$67.27 - $86.96 $30.2 Million - $39 Million
448,911 Added 34.67%
1,743,794 $148 Million
Q2 2025

Aug 14, 2025
SELL
$55.17 - $71.22 $5.7 Million - $7.35 Million
-103,260 Reduced 7.39%
1,294,883 $88.2 Million
Q1 2025

May 15, 2025
BUY
$60.0 - $75.26 $30.4 Million - $38.1 Million
506,484 Added 56.8%
1,398,143 $84.7 Million
Q4 2024

Feb 14, 2025
BUY
$65.08 - $83.38 $52 Million - $66.6 Million
798,877 Added 861.03%
891,659 $61.6 Million
Q3 2024

Nov 14, 2024
SELL
$57.33 - $68.61 $3.6 Million - $4.3 Million
-62,713 Reduced 40.33%
92,782 $6.13 Million
Q2 2024

Aug 14, 2024
SELL
$51.18 - $63.75 $121 Million - $150 Million
-2,359,139 Reduced 93.82%
155,495 $9.43 Million
Q1 2024

May 15, 2024
BUY
$56.55 - $66.59 $10.1 Million - $11.8 Million
177,852 Added 7.61%
2,514,634 $143 Million
Q4 2023

Feb 14, 2024
BUY
$52.16 - $64.19 $13.1 Million - $16.1 Million
251,317 Added 12.05%
2,336,782 $147 Million
Q3 2023

Nov 16, 2023
BUY
$57.77 - $65.93 $18.1 Million - $20.7 Million
313,731 Added 17.71%
2,085,465 $120 Million
Q2 2023

Aug 14, 2023
BUY
$60.95 - $75.51 $6.31 Million - $7.82 Million
103,516 Added 6.21%
1,771,734 $110 Million
Q1 2023

May 15, 2023
BUY
$70.23 - $86.01 $23.8 Million - $29.1 Million
338,311 Added 25.44%
1,668,218 $121 Million
Q4 2022

Feb 14, 2023
BUY
$67.18 - $84.11 $11.7 Million - $14.6 Million
173,622 Added 15.02%
1,329,907 $107 Million
Q3 2022

Nov 15, 2022
BUY
$66.18 - $82.86 $1.51 Million - $1.89 Million
22,753 Added 2.01%
1,156,285 $77.1 Million
Q2 2022

Aug 15, 2022
SELL
$66.18 - $83.18 $1.28 Million - $1.61 Million
-19,339 Reduced 1.68%
1,133,532 $86.1 Million
Q1 2022

May 16, 2022
BUY
$66.02 - $79.71 $5.03 Million - $6.07 Million
76,180 Added 7.08%
1,152,871 $91.6 Million
Q4 2021

Feb 14, 2022
SELL
$63.34 - $74.11 $3.1 Million - $3.63 Million
-48,964 Reduced 4.35%
1,076,691 $79 Million
Q3 2021

Nov 15, 2021
BUY
$68.67 - $84.02 $7.65 Million - $9.36 Million
111,392 Added 10.98%
1,125,655 $77.4 Million
Q2 2021

Aug 16, 2021
BUY
$79.87 - $87.53 $18.1 Million - $19.8 Million
226,110 Added 28.69%
1,014,263 $85.3 Million
Q1 2021

May 17, 2021
BUY
$76.02 - $100.5 $10.3 Million - $13.6 Million
135,415 Added 20.75%
788,153 $64.1 Million
Q4 2020

Feb 16, 2021
BUY
$80.74 - $97.7 $6.09 Million - $7.37 Million
75,469 Added 13.07%
652,738 $56.8 Million
Q3 2020

Nov 16, 2020
BUY
$85.07 - $109.69 $16.5 Million - $21.2 Million
193,571 Added 50.45%
577,269 $51.8 Million
Q2 2020

Aug 17, 2020
SELL
$74.18 - $108.93 $27.8 Million - $40.9 Million
-375,100 Reduced 49.43%
383,698 $39.9 Million
Q1 2020

May 15, 2020
BUY
$63.18 - $85.97 $7.25 Million - $9.86 Million
114,711 Added 17.81%
758,798 $55.6 Million
Q4 2019

Feb 14, 2020
BUY
$73.04 - $95.72 $20.5 Million - $26.9 Million
280,937 Added 77.36%
644,087 $56.2 Million
Q3 2019

Nov 14, 2019
BUY
$72.82 - $86.52 $12 Million - $14.3 Million
164,703 Added 83.0%
363,150 $27 Million
Q2 2019

Aug 13, 2019
SELL
$73.52 - $88.7 $7.37 Million - $8.89 Million
-100,233 Reduced 33.56%
198,447 $16.9 Million
Q1 2019

May 14, 2019
BUY
$63.56 - $88.17 $5.99 Million - $8.32 Million
94,320 Added 46.15%
298,680 $25.7 Million
Q4 2018

Feb 14, 2019
BUY
$58.5 - $69.94 $7 Million - $8.37 Million
119,630 Added 141.19%
204,360 $13 Million
Q3 2018

Nov 14, 2018
BUY
$61.75 - $74.23 $1.32 Million - $1.58 Million
21,340 Added 33.66%
84,730 $5.85 Million
Q2 2018

Aug 14, 2018
BUY
$60.85 - $83.98 $3.86 Million - $5.32 Million
63,390 New
63,390 $4.25 Million
Q1 2018

May 15, 2018
SELL
$83.06 - $100.98 $183,562 - $223,165
-2,210 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$109.15 - $138.27 $241,221 - $305,576
2,210
2,210 $258,000

Others Institutions Holding INCY

# of Institutions
796
Shares Held
205M
Call Options Held
638K
Put Options Held
635K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email